301 related articles for article (PubMed ID: 33300130)
1. Identification of human cytotoxic ILC3s.
Krabbendam L; Heesters BA; Kradolfer CMA; Spits H; Bernink JH
Eur J Immunol; 2021 Apr; 51(4):811-823. PubMed ID: 33300130
[TBL] [Abstract][Full Text] [Related]
2. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
3. CD127+ CD94+ innate lymphoid cells expressing granulysin and perforin are expanded in patients with Crohn's disease.
Krabbendam L; Heesters BA; Kradolfer CMA; Haverkate NJE; Becker MAJ; Buskens CJ; Bemelman WA; Bernink JH; Spits H
Nat Commun; 2021 Oct; 12(1):5841. PubMed ID: 34615883
[TBL] [Abstract][Full Text] [Related]
4. Innate lymphoid cells: from helper to killer.
Krabbendam L; Bernink JH; Spits H
Curr Opin Immunol; 2021 Feb; 68():28-33. PubMed ID: 32971468
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
6. An in vitro model of innate lymphoid cell function and differentiation.
Allan DS; Kirkham CL; Aguilar OA; Qu LC; Chen P; Fine JH; Serra P; Awong G; Gommerman JL; Zúñiga-Pflücker JC; Carlyle JR
Mucosal Immunol; 2015 Mar; 8(2):340-51. PubMed ID: 25138665
[TBL] [Abstract][Full Text] [Related]
7. Innate lymphoid cells and cancer: Role in tumor progression and inhibition.
Yuan X; Rasul F; Nashan B; Sun C
Eur J Immunol; 2021 Sep; 51(9):2188-2205. PubMed ID: 34189723
[TBL] [Abstract][Full Text] [Related]
8. Human innate lymphoid cells.
Hazenberg MD; Spits H
Blood; 2014 Jul; 124(5):700-9. PubMed ID: 24778151
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.
Bernink JH; Krabbendam L; Germar K; de Jong E; Gronke K; Kofoed-Nielsen M; Munneke JM; Hazenberg MD; Villaudy J; Buskens CJ; Bemelman WA; Diefenbach A; Blom B; Spits H
Immunity; 2015 Jul; 43(1):146-60. PubMed ID: 26187413
[TBL] [Abstract][Full Text] [Related]
10. Innate Lymphoid Cells in the Maternal and Fetal Compartments.
Miller D; Motomura K; Garcia-Flores V; Romero R; Gomez-Lopez N
Front Immunol; 2018; 9():2396. PubMed ID: 30416502
[TBL] [Abstract][Full Text] [Related]
11. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.
Satoh-Takayama N; Lesjean-Pottier S; Vieira P; Sawa S; Eberl G; Vosshenrich CA; Di Santo JP
J Exp Med; 2010 Feb; 207(2):273-80. PubMed ID: 20142427
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua.
Vacca P; Chiossone L; Mingari MC; Moretta L
Front Immunol; 2019; 10():170. PubMed ID: 30800126
[TBL] [Abstract][Full Text] [Related]
13. Lymphoid tissue inducer-A divergent member of the ILC family.
Zhong C; Zheng M; Zhu J
Cytokine Growth Factor Rev; 2018 Aug; 42():5-12. PubMed ID: 29454785
[TBL] [Abstract][Full Text] [Related]
14. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells.
Hughes T; Briercheck EL; Freud AG; Trotta R; McClory S; Scoville SD; Keller K; Deng Y; Cole J; Harrison N; Mao C; Zhang J; Benson DM; Yu J; Caligiuri MA
Cell Rep; 2014 Jul; 8(1):150-62. PubMed ID: 24953655
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.
Mizuno S; Mikami Y; Kamada N; Handa T; Hayashi A; Sato T; Matsuoka K; Matano M; Ohta Y; Sugita A; Koganei K; Sahara R; Takazoe M; Hisamatsu T; Kanai T
Inflamm Bowel Dis; 2014 Aug; 20(8):1426-34. PubMed ID: 24991784
[TBL] [Abstract][Full Text] [Related]
16. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells.
Crellin NK; Trifari S; Kaplan CD; Cupedo T; Spits H
J Exp Med; 2010 Feb; 207(2):281-90. PubMed ID: 20142432
[TBL] [Abstract][Full Text] [Related]
17. T-BET drives the conversion of human type 3 innate lymphoid cells into functional NK cells.
Kiekens L; Wahlen S; Persyn E; De Vos Z; Taghon T; Vandekerckhove B; Leclercq G
Front Immunol; 2022; 13():975778. PubMed ID: 36330517
[TBL] [Abstract][Full Text] [Related]
18. KLRG1 and NKp46 discriminate subpopulations of human CD117
Nagasawa M; Heesters BA; Kradolfer CMA; Krabbendam L; Martinez-Gonzalez I; de Bruijn MJW; Golebski K; Hendriks RW; Stadhouders R; Spits H; Bal SM
J Exp Med; 2019 Aug; 216(8):1762-1776. PubMed ID: 31201208
[TBL] [Abstract][Full Text] [Related]
19. Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15.
Lieto LD; Borrego F; You CH; Coligan JE
J Immunol; 2003 Nov; 171(10):5277-86. PubMed ID: 14607929
[TBL] [Abstract][Full Text] [Related]
20. Dichotomous Regulation of Acquired Immunity by Innate Lymphoid Cells.
Ebihara T
Cells; 2020 May; 9(5):. PubMed ID: 32403291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
